This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Key features and functionalities of KAM technology typically include: Account Planning and Mapping By Location : KAM technology facilitates the creation of comprehensive account plans, enabling organizations to define clear objectives, strategies, and action plans for each key account.
Now, as the global pandemic re-writes the rules of customer engagement and removes at least in the short term, direct face-to-face contact with healthcare stakeholders, pharma companies are plotting their next move. For any pharma organization sitting on the sidelines, “ waiting for the storm to pass ,” our message is clear.
More than a sense of being stopped in one’s tracks, the pandemic has had the interesting effect of preventing pharmaceutical sales organizations from “speeding up the mess” of coin-operated sales pitches and has made companies acutely aware of the limits of product-centric physician contact models. Things have changed.
More than a sense of being stopped in one’s tracks, the pandemic has had the interesting effect of preventing pharmaceutical sales organizations from “speeding up the mess” of coin-operated sales pitches and has made companies acutely aware of the limits of product-centric physician contact models. Things have changed.
The need to accelerate the shift from transactional sales pitches aimed at promoting a product to a physician for an unmet patient need to creating solutions designed for a broader set of account stakeholder, has been a nagging factor for every pharma commercial organization. Things have changed. Priorities have shifted.
Today, as advisors in the strategic account management space, we are surprised and disheartened to see that marketing is often not only missing at the strategic account team table but also working from an inside-out products focus, rather than an outside-in customer focus. So, what does marketing bring to the table?
We organize all of the trending information in your field so you don't have to. Join 105,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content